A comparison between the effects of icodextrin and glucose 2.27% on plasma volume in peritoneal dialysis patients

A comparison between the effects of icodextrin and glucose 2.27% on plasma volume in peritoneal dialysis patients - icodextrin and plasmavolume

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30588

Enrollment

Registered

2007-01-31

Start date

2007-01-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal failure renal insufficiency

Interventions

Blood sampling 24-hours blood pressure monitoring I-125 albumine method for assessment of plasma volume Bromide dilution method for assessment of the extracellular volume Multifrequency bioimpedance a

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: clinical stable patients treated with peritoneal dialysis

Exclusion criteria

Exclusion criteria: chronic heart failure NYHA III or higher known hypersensitivity to icodextrin pacemaker pregnancy younger than 18 years inability to give informed consent within one month of peritonitis patients unable to stop icodextrin on clinical grounds

Design outcomes

Primary

Measure	Time frame
In this study the effects of glucose 2.27% and icodextrin 7.5% will be compared for the long dwell on plasma volume, extracellular volume and blood pressure control.	—

Secondary

Measure	Time frame
xx	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)